Mereo BioPharma (MREO) EBIT (2023 - 2026)
Mereo BioPharma's (MREO) quarterly EBIT came in at -$8.8 million in Q1 2026, up 21.75% year-on-year from -$7.2 million in Q1 2025, and down 4.48% on a QoQ basis from -$8.4 million in Q4 2025.
Mereo BioPharma (MREO) EBIT (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 4 years of EBIT data on file, last reported at -$8.8 million in Q1 2026.
- On a quarterly basis, EBIT rose 21.75% year-over-year to -$8.8 million in Q1 2026; TTM through Mar 2026 was -$37.7 million, a 22.59% increase from a year earlier, with the FY2025 full-year figure at -$40.1 million, up 15.32% from the prior year.
- EBIT for Q1 2026 stood at -$8.8 million, down from -$8.4 million in the prior quarter.
- Over the last five years, EBIT for MREO reached as high as -$811000.0 in Q2 2023 and fell as low as -$15.3 million in Q4 2024.
- Historically, EBIT has averaged -$9.6 million across 4 years, with a median of -$9.9 million in 2024.
- Across the five-year window, EBIT sank 1480.02% in 2024 and soared 45.07% in 2025, its largest moves.
- Year by year, EBIT stood at -$7.1 million in 2023, then tumbled by 114.3% to -$15.3 million in 2024, then soared by 45.07% to -$8.4 million in 2025, then slipped by 4.48% to -$8.8 million in 2026.
- Per Business Quant data, the three most recent EBIT figures were -$8.8 million in Q1 2026, -$8.4 million in Q4 2025, and -$10.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Mereo BioPharma | 229.80 Mn | 229.80 Mn | - | -8.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.77 Mn |
| Dec 31, 2025 | -8.39 Mn |
| Sep 30, 2025 | -10.02 Mn |
| Jun 30, 2025 | -10.50 Mn |
| Mar 31, 2025 | -11.20 Mn |
| Dec 31, 2024 | -15.28 Mn |
| Sep 30, 2024 | -9.37 Mn |
| Jun 30, 2024 | -12.81 Mn |
| Mar 31, 2024 | -9.90 Mn |
| Dec 31, 2023 | -7.13 Mn |
| Sep 30, 2023 | -9.07 Mn |
| Jun 30, 2023 | -811,000.00 |
| Mar 31, 2023 | -11.41 Mn |